Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v2-FR
Language English French
Date Updated 2023-01-24 2022-12-02
Drug Identification Number 02487721 02487721
Brand name ACH-APIXABAN ACH-APIXABAN
Common or Proper name APIXABAN APIXABAN
Company Name ACCORD HEALTHCARE INC ACCORD HEALTHCARE INC
Ingredients APIXABAN APIXABAN
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60 60
ATC code B01AF B01AF
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-02 2022-12-02
Estimated end date
Actual end date 2023-01-23 2022-12-28
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments